Global Active Pharmaceutical Ingredient Cdmo Market Size & Outlook
The active pharmaceutical ingredient cdmo industry worldwide is expected to reach a projected revenue of US$ 193,655.1 million by 2030. A compound annual growth rate of 7.3% is expected of the worldwide active pharmaceutical ingredient cdmo industry from 2024 to 2030.
Revenue, 2023 (US$M)
$118,550.8
Forecast, 2030 (US$M)
$193,655.1
CAGR, 2024 - 2030
7.3%
Report Coverage
Worldwide
Global active pharmaceutical ingredient cdmo market, 2018-2030 (US$M)
Related Markets
Global active pharmaceutical ingredient cdmo market highlights
- The global active pharmaceutical ingredient cdmo market generated a revenue of USD 118,550.8 million in 2023 and is expected to reach USD 193,655.1 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 7.3% by 2030.
- In terms of segment, traditional active pharmaceutical ingredient (traditional api) accounted for a revenue of USD 47,227.3 million in 2023.
- Antibody Drug Conjugate (ADC is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, Asia Pacific was the largest revenue generating market in 2023.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 118,550.8 million |
| Market revenue in 2030 | USD 193,655.1 million |
| Growth rate | 7.3% (CAGR from 2023 to 2030) |
| Largest segment | Traditional active pharmaceutical ingredient (traditional api) |
| Fastest growing segment | Antibody Drug Conjugate (ADC |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Traditional Active Pharmaceutical Ingredient (Traditional API), Highly Potent Active Pharmaceutical Ingredient (HP-API), Antibody Drug Conjugate (ADC |
Other key industry trends
- In terms of revenue, the North America accounted for 28.2% of the global active pharmaceutical ingredient cdmo market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, UAE is the fastest growing regional market and is projected to reach USD 937.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Active Pharmaceutical Ingredient CDMO Market Scope
Active pharmaceutical ingredient cdmo market segmentation & scope
Traditional Active Pharmaceutical Ingredient (Traditional API)
Highly Potent Active Pharmaceutical Ingredient (HP-API)
Antibody Drug Conjugate (ADC
Others
Active Pharmaceutical Ingredient CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global active pharmaceutical ingredient cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to active pharmaceutical ingredient cdmo market will help companies and investors design strategic landscapes.
Traditional active pharmaceutical ingredient (traditional api) was the largest segment with a revenue share of 39.84% in 2023. Horizon Databook has segmented the Global active pharmaceutical ingredient cdmo market based on traditional active pharmaceutical ingredient (traditional api), highly potent active pharmaceutical ingredient (hp-api), antibody drug conjugate (adc covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Active Pharmaceutical Ingredient CDMO Product Outlook (Revenue, USD Million, 2018-2030)
- Traditional Active Pharmaceutical Ingredient (Traditional API)
- Highly Potent Active Pharmaceutical Ingredient (HP-API)
- Antibody Drug Conjugate (ADC
- Others
- Global Active Pharmaceutical Ingredient CDMO Synthesis Outlook (Revenue, USD Million, 2018-2030)
- Synthetic
- Biotech
- Global Active Pharmaceutical Ingredient CDMO Drug Outlook (Revenue, USD Million, 2018-2030)
- Innovative
- Generics
- Global Active Pharmaceutical Ingredient CDMO Workflow Outlook (Revenue, USD Million, 2018-2030)
- Clinical
- Commercial
- Global Active Pharmaceutical Ingredient CDMO Application Outlook (Revenue, USD Million, 2018-2030)
- Oncology
- Hormonal
- Glaucoma
- Cardiovascular disease
- Diabetes
- Others
Reasons to subscribe to Global active pharmaceutical ingredient cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global active pharmaceutical ingredient cdmo market databook
-
Our clientele includes a mix of active pharmaceutical ingredient cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global active pharmaceutical ingredient cdmo market , including forecasts for subscribers. This global databook contains high-level insights into Global active pharmaceutical ingredient cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global active pharmaceutical ingredient cdmo market size, by regions, 2018-2030 (US$M)
Top 10 countries: Active pharmaceutical ingredient cdmo market size, 2023 (US$M)
Global active pharmaceutical ingredient cdmo market share, by product, 2023 & 2030 (%, US$M)
Active Pharmaceutical Ingredient Cdmo Market: Opportunity Assessment By Country
Global active pharmaceutical ingredient cdmo market, by region, 2023 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
